Navigation Links
AstraZeneca Calls on All Americans to Join US AGAINST ATHERO to Fight the Nation's Number One Killer
Date:3/24/2009

teries for those unable to experience the Artery Explorer in person.

About Atherosclerosis (Athero)

Athero is the progressive buildup of plaque -- made of fat, cholesterol, and other substances -- in the inner walls of the arteries.(1) Elevated cholesterol and other risk factors can contribute to the disease, and for many, the disease progresses silently, with no visible signs or symptoms.(2) Athero is the leading cause of coronary heart disease (CHD), which affects more than 1.2 million Americans and is the No. 1 killer in the U.S.(3) Approximately 785,000 Americans will have their first heart attack in 2009 and about every minute someone will die from a coronary event.(2) Athero is also a leading cause of stroke, which affects nearly 800,000 Americans each year.(2) Together, CHD and stroke kill more Americans every year than all cancers combined.

About US AGAINST ATHERO

US AGAINST ATHERO is a movement sponsored by AstraZeneca to increase our nation's awareness of athero with hopes that all Americans will take steps to take care of their arteries. Through education and information, US AGAINST ATHERO supports people in becoming advocates for their own health and for the health of others. To join the US AGAINST ATHERO effort, please visit www.athero.com.

About AstraZeneca

AstraZeneca is engaged in the research, development, manufacturing and marketing of meaningful prescription medicines and in the supply of health care services. AstraZeneca is one of the world's leading pharmaceutical companies with global health care sales of $31.6 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infectious disease medicines. In the United States, AstraZeneca is a $13.5 billion dollar health care business.

For more information about AstraZeneca in the US or our AZ&
'/>"/>

SOURCE AstraZeneca
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. BioDuro and AstraZeneca Expand Collaboration to Optimize Discovery Research for Respiratory and Inflammation Indications
2. Novartis/Schering-Ploughs Drug Will Replace AstraZenecas Symbicort as Decision Resources Clinical Gold Standard by 2012 for the Treatment of Asthma
3. AstraZeneca Implements Customized Cytel East(R) Software for More Accurate Trial Monitoring and Clinical Data Analysis
4. AstraZeneca Appoints Graham Baker Vice President and Chief Financial Officer for North America
5. AstraZeneca Nobel Medicine Initiative to Increase Interest in the Nobel Prize in Physiology or Medicine
6. AstraZeneca and M. D. Anderson Renew Cancer Research Collaboration
7. FDA Approves AstraZenecas SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania
8. Melior Enters Research Collaboration with AstraZeneca
9. Abbott and AstraZeneca Expand Relationship to Include Co-Promotion of CRESTOR(R)
10. AstraZeneca Survey: Healthcare Professionals Leading Source of Information on Companys Prescription Savings Programs
11. Weitz & Luxenberg Files Seroquel Diabetes Lawsuit Against AstraZeneca
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 2015 College of DuPage students Sam ... invaluable real-world experiences while serving biophysics internships at the ... The students will be working as a part of ... at IIT. The internship came about from a discussion ... Dr. Kathy Finan , Biology; and Dr. Wereszczynski ...
(Date:7/2/2015)... Amici Procurement Migrates to the ... Procurement has chosen Microsoft Cloud Solution Provider iomart ... 365.      (Logo: http://photos.prnewswire.com/prnh/20121126/579634) , ... in the bio-tech sector with a unique procurement service, ... to help them obtain best value. Its IT platform ...
(Date:7/2/2015)... ... July 02, 2015 , ... ... of surgical instruments in Orthopedics, announced today the acquisition of Turner Medical, ... largest provider of surgical instruments to the Spine Industry. The acquisition of Turner ...
(Date:7/1/2015)... TRIANGLE PARK, N.C. and ... agricultural research firm AgBiome, and Genective, key developer ... to accelerate the discovery of new generations of ... traits for insect control to counter the realities ... partner with Genective, aligning AgBiome,s unique insect control ...
Breaking Biology Technology:COD Students Participate in Prestigious Summer Internships 2Biotech Procurement Company Moves to Office 365 with iomart 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 2In'Tech Medical Acquires Turner Medical to Become a World Leader in Orthopedic Contract-Manufacturing 3AgBiome and Genective collaborate to create novel insect-resistant crops 2
... (Nasdaq: PRXL ) will release Second Quarter Fiscal ... the close of the,stock market. The announcement will be ... the PR Newswire website at, http://www.prnewswire.com ., PAREXEL ... 10:00 a.m. ET,on Thursday, January 24, 2008 to discuss ...
... 4 Cerimon,Pharmaceuticals, Inc. announced today that Matthew ... established position, and Vice President of,Business Development and ... and corporate attorney with broad experience with large,pharmaceutical, ... and,Europe. In the business development role, he replaces ...
... Will be ... Effient(TM), TOKYO and INDIANAPOLIS, ... Company (NYSE: LLY ) today,announced that on Wednesday, Dec. 26, 2007, ... and Drug Administration,(FDA). Prasugrel is an oral antiplatelet agent, initially in development,for ...
Cached Biology Technology:PAREXEL Announces Date of Second Quarter Fiscal Year 2008 Earnings Release and Conference Call 2Cerimon Pharmaceuticals Names Matthew J. Meyer its General Counsel and Vice President of Business Development and Licensing 2Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration 2Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration 3Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration 4
(Date:6/10/2015)... , June 10, 2015 ... Sensor Market by Technology (Ultrasound, TOF, Structured Light, ... Electronics, Entertainment, Automotive) and by Geography - Trends ... MarketsandMarkets, the market is expected to reach $3,319.71 ... 25.51% between 2015 and 2020. Browse ...
(Date:6/9/2015)... 09, 2015 Research and Markets  ( ... "Gesture Recognition & Touchless Sensing Market by ... & Others), Product (Biometric & Sanitary Equipment) & ... report to their offering. The total ... to reach $ 23.55 Billion by 2020 at ...
(Date:6/8/2015)... 2015  The Secure Identity & Biometrics ... Troy Potter of L-3 National Security ... a non-profit association that was established in February ... implementation of solutions that protect and secure identity ... Photo - ...
Breaking Biology News(10 mins):3D Sensor Market Worth $3,319.71 Million by 2020 23D Sensor Market Worth $3,319.71 Million by 2020 33D Sensor Market Worth $3,319.71 Million by 2020 4Global Gesture Recognition & Touchless Sensing (Technology, Application & Products) Market 2015-2020 2Secure Identity & Biometrics Association (SIBA) Names Troy Potter of L-3 National Security Solutions as Chairman 2Secure Identity & Biometrics Association (SIBA) Names Troy Potter of L-3 National Security Solutions as Chairman 3Secure Identity & Biometrics Association (SIBA) Names Troy Potter of L-3 National Security Solutions as Chairman 4Secure Identity & Biometrics Association (SIBA) Names Troy Potter of L-3 National Security Solutions as Chairman 5
... Today sees the launch of BioModels, the world's ... the result of a collaboration led by the ... an international group that develops open-source standards to ... Graduate Institute (USA), the Systems Biology Institute (Japan) ...
... scientists has made an important advance in our understanding ... the industrialized world. Professor Jeremy R. Jass, who holds ... University in Montreal, and colleagues in Australia and Japan ... be inherited. The new syndrome is characterized by distinctive ...
... of chimpanzees and gorillas were infected with a deadly retrovirus ... no evidence it infected ancestors of modern-day humans, according to ... split off the evolutionary tree from primates, researchers said. The ... such great apes as chimps and gorillas. The research appears ...
Cached Biology News:A new way to share models of biological systems 2Important discovery about second most fatal cancer 2Retrovirus struck ancestors of chimpanzees and gorillas millions of years ago, but did not affect ancestral humans 2Retrovirus struck ancestors of chimpanzees and gorillas millions of years ago, but did not affect ancestral humans 3
B.D. Hames and D.M. Glover (1996) • This issue covers T-Cell antigen receptor genes; T-Lymphocyte signal transduction; B-Cell activation antibody engineering and the complement system and other ...
...
LabFax: Immunochemistry...
Mycoplasma Removal Agent (MRA) has been developed for cell culture, to combat the widespread problems caused by contamination of cell cultures with mycoplasma....
Biology Products: